NEA Management Company as of Sept. 30, 2018
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 17.5 | $407M | 10M | 39.01 | |
| Adaptimmune Therapeutics (ADAP) | 9.3 | $215M | 16M | 13.56 | |
| Senseonics Hldgs (SENS) | 6.4 | $147M | 31M | 4.77 | |
| Rhythm Pharmaceuticals (RYTM) | 6.2 | $143M | 4.9M | 29.17 | |
| Glycomimetics (GLYC) | 5.7 | $131M | 9.1M | 14.40 | |
| Allakos (ALLK) | 4.4 | $102M | 2.3M | 44.99 | |
| Ra Pharmaceuticals | 4.3 | $99M | 5.5M | 18.09 | |
| Crispr Therapeutics (CRSP) | 4.0 | $93M | 2.1M | 44.35 | |
| Obseva Sa | 3.6 | $83M | 4.6M | 18.03 | |
| Mersana Therapeutics (MRSN) | 3.5 | $81M | 8.1M | 10.00 | |
| Epizyme | 3.0 | $69M | 6.5M | 10.60 | |
| Liquidia Technologies (LQDA) | 2.9 | $68M | 2.5M | 27.43 | |
| Ardelyx (ARDX) | 2.9 | $67M | 15M | 4.35 | |
| AVEO Pharmaceuticals | 2.7 | $62M | 19M | 3.31 | |
| Synlogic | 2.6 | $60M | 4.2M | 14.21 | |
| Bloom Energy Corp (BE) | 2.0 | $45M | 1.3M | 34.08 | |
| Dermira | 1.6 | $38M | 3.5M | 10.90 | |
| Surface Oncology | 1.6 | $36M | 3.3M | 10.94 | |
| Aurinia Pharmaceuticals (AUPH) | 1.4 | $32M | 4.8M | 6.64 | |
| Champions Oncology (CSBR) | 1.2 | $27M | 1.6M | 17.47 | |
| Regulus Therapeutics | 1.1 | $26M | 11M | 2.37 | |
| Lexicon Pharmaceuticals (LXRX) | 1.1 | $25M | 2.4M | 10.67 | |
| Mei Pharma | 1.1 | $25M | 5.7M | 4.31 | |
| Clementia | 1.0 | $24M | 2.1M | 11.15 | |
| Affimed Therapeutics B V | 1.0 | $22M | 5.1M | 4.35 | |
| Achaogen | 0.9 | $21M | 5.2M | 3.99 | |
| Strongbridge Bioph shs usd | 0.9 | $20M | 4.1M | 4.85 | |
| Genocea Biosciences | 0.8 | $20M | 25M | 0.78 | |
| Verona Pharma Plc ads (VRNA) | 0.7 | $15M | 1.2M | 12.51 | |
| Nightstar Therapeutics | 0.6 | $15M | 714k | 20.43 | |
| ArQule | 0.6 | $14M | 2.5M | 5.66 | |
| Dasan Zhone Solutions | 0.6 | $14M | 956k | 14.19 | |
| Proteostasis Therapeutics In | 0.6 | $13M | 5.6M | 2.41 | |
| Rigel Pharmaceuticals | 0.5 | $10M | 3.2M | 3.21 | |
| Trevena | 0.3 | $8.1M | 3.8M | 2.12 | |
| Cti Biopharma | 0.3 | $8.1M | 3.8M | 2.16 | |
| Trillium Therapeutics, Inc. Cmn | 0.3 | $7.3M | 1.3M | 5.80 | |
| Tracon Pharmaceuticals | 0.3 | $7.1M | 3.5M | 2.05 | |
| Erytech Pharma Sa | 0.2 | $5.4M | 625k | 8.57 | |
| Endologix | 0.2 | $4.8M | 2.5M | 1.91 | |
| Arsanis | 0.1 | $3.2M | 2.0M | 1.62 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $2.6M | 1.3M | 2.00 | |
| Akari Therapeutics | 0.1 | $1.2M | 452k | 2.56 | |
| Aytu Bioscience | 0.0 | $6.0k | 2.2k | 2.67 |
